A promising leap in treating large granular lymphocytic leukemia: reflections on a Multicenter Phase II Study of thalidomide-based therapy
Blood Sci
.
2025 Jul 2;7(3):e00239.
doi: 10.1097/BS9.0000000000000239.
eCollection 2025 Sep.
Authors
Xue Kong
1
,
Ken H Young
1
Affiliation
1
Duke University School of Medicine, Duke Cancer Center, Durham, NC 27710, USA.
PMID:
40612250
PMCID:
PMC12225999
DOI:
10.1097/BS9.0000000000000239
No abstract available